AIF Capital Exits Famy Care Through a Strategic Sale to Mylan (Asia)

Global pharmaceutical company Mylan has signed a definitive agreement to acquire certain female health care businesses from India-based oral contraceptive pill manufacturer Famy Care for US$750 million, plus additional contingent payments of up to US$50 million, facilitating an exit for Asia-focused private equity firm AIF Capital. AIF Capital originally invested… Read More

The Abraaj Group Invests in BRN Sleep Products with EBRD (CEE and CIS, MENA)

Global growth markets investor The Abraaj Group has acquired a stake in BRN Yatak Baza Ev Tekstili İnşaat Sanayi Ticaret (BRN Sleep Products), a Turkey-based mattress and sleep products manufacturer, in partnership with development finance institution EBRD. Financial details of the transaction, which was structured through Abraaj’s Anatolia Growth Capital… Read More



(default archive template)